3B Blackbio DX Ltd Share Price ₹1,245 | P/E 20.5

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of 3B Blackbio DX Ltd

Quarter-by-quarter operating performance

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales +	15	18	14	19	18	23	19	29	25	22	22	34	50
Expenses +	7	11	8	11	9	13	8	13	10	15	10	19	29
Operating Profit	7	7	6	8	9	10	11	16	15	8	12	15	22
OPM %	50%	41%	45%	41%	50%	43%	56%	55%	59%	35%	53%	43%	43%
Other Income +	3	1	3	3	3	4	4	3	3	5	4	6	6
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0	0	1	0
Profit before tax	10	8	9	10	11	14	14	19	18	13	16	20	27
Tax %	22%	38%	22%	26%	24%	36%	21%	23%	24%	36%	20%	23%	16%
Net Profit +	8	5	7	8	9	9	11	15	13	8	13	15	22
EPS in Rs	8.96	7.72	9.71	10.46	10.16	10.33	12.97	17.07	15.61	9.79	14.67	17.14	25.32

Financials of 3B Blackbio DX Ltd

Annual income statement trend

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales +	22	19	17	16	23	23	29	227	81	62	74	96	129
Expenses +	21	18	16	14	18	16	20	77	44	33	41	46	73
Operating Profit	1	1	2	3	5	7	9	150	37	29	33	50	56
OPM %	6%	7%	9%	16%	23%	31%	32%	66%	46%	47%	44%	52%	44%
Other Income +	0	0	0	0	0	1	2	3	7	7	13	15	20
Interest	1	1	1	1	1	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	1	1	1	1	1	1	1	2
Profit before tax	0	0	0	1	5	7	10	152	43	35	44	64	75
Tax %	14%	23%	23%	19%	24%	25%	23%	25%	26%	27%	28%	25%
Net Profit +	0	0	0	1	3	5	8	114	32	26	32	48	58
EPS in Rs	0.59	0.36	0.51	1.76	5.35	8.18	10.24	151.66	42.89	34.55	37.40	55.57	66.92
Dividend Payout %	0%	0%	0%	17%	9%	6%	7%	6%	24%	8%	8%	7%

Financials of 3B Blackbio DX Ltd

Capital structure and asset base

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	6	6	6	6	6	6	7	7	7	9	9	9	9
Reserves	4	4	4	5	12	16	25	125	146	185	214	260	290
Borrowings +	7	8	8	9	6	6	4	2	3	2	1	0	0
Other Liabilities +	7	7	6	6	6	8	9	59	37	19	24	27	42
Total Liabilities	24	25	24	26	30	36	45	194	192	214	248	296	341
Fixed Assets +	4	4	3	3	4	4	4	5	7	8	7	7	17
CWIP	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	0	0	0	0	0	0	1	59	93	92	117	156	160
Other Assets +	20	21	21	22	26	32	40	130	93	114	123	132	163
Total Assets	24	25	24	26	30	36	45	194	192	214	248	296	341

Financials of 3B Blackbio DX Ltd

Operating, investing and financing cash movement

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	0	0	1	1	2	4	7	98	37	20	27	43
Cash from Investing Activity +	-0	-0	-0	-0	-1	-1	-1	-70	-28	15	-20	-33
Cash from Financing Activity +	0	-0	-1	-0	0	-1	1	-2	-15	-5	-4	-3
Net Cash Flow	0	-0	0	0	1	2	7	26	-6	30	3	7
Free Cash Flow	-0	0	1	0	1	3	6	96	35	18	26	42
CFO/OP	25%	23%	69%	36%	52%	71%	101%	90%	129%	100%	115%	116%

Financials of 3B Blackbio DX Ltd

Working capital efficiency and return ratios

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	213	262	283	321	259	290	252	56	136	200	179	138
Inventory Days	120	145	143	175						164	141	124
Days Payable	189	218	203	186						69	66	28
Cash Conversion Cycle	144	188	223	310	259	290	252	56	136	296	253	235
Working Capital Days	144	175	205	247	253	287	275	65	162	241	215	169
ROCE %	7%	7%	7%	13%	24%	28%	31%	162%	27%	19%	21%	26%